Literature DB >> 25660648

On-label and off-label drugs used in the treatment of male infertility.

Mahmoud Chehab1, Alosh Madala1, J C Trussell2.   

Abstract

Infertility affects 6.1 million U.S. couples-representing 10% of reproductive-age adults and 15% of all couples trying to conceive. Half of the time, infertility is the result of an abnormal semen analysis or other male factors, with 40%-50% of these infertile men diagnosed with idiopathic or nonclassifiable infertility. While the role of hormone therapy for men with an identified abnormality is well defined, the literature remains inconclusive and controversial regarding hormone manipulation using empirical (off-label) medical therapies for men with idiopathic infertility. This manuscript reviews the commonly used off-label medications used to treat idiopathic male factor infertility: clomiphene citrate, letrozole/anastrozole, exogenous androgens, and pentoxifylline.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Infertile men; empirical; idiopathic; off-label

Mesh:

Substances:

Year:  2015        PMID: 25660648     DOI: 10.1016/j.fertnstert.2014.12.122

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

1.  Clomiphene citrate rescue of spermatogenesis in men with infertility while remaining on finasteride: A case report.

Authors:  Christopher Wu; Ellen Forbes; Keith Allen Jarvi
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

2.  The effect of Medicaid expansion on prescriptions for breast cancer hormonal therapy medications.

Authors:  Johanna Catherine Maclean; Michael T Halpern; Steven C Hill; Michael F Pesko
Journal:  Health Serv Res       Date:  2020-04-17       Impact factor: 3.402

Review 3.  Testis Development and Fertility Potential in Boys with Klinefelter Syndrome.

Authors:  Shanlee M Davis; Alan D Rogol; Judith L Ross
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09-28       Impact factor: 4.741

4.  Sulforaphane Prevents Angiotensin II-Induced Testicular Cell Death via Activation of NRF2.

Authors:  Yonggang Wang; Hao Wu; Ying Xin; Yang Bai; Lili Kong; Yi Tan; Feng Liu; Lu Cai
Journal:  Oxid Med Cell Longev       Date:  2017-01-16       Impact factor: 6.543

Review 5.  Empiric medical therapy with hormonal agents for idiopathic male infertility.

Authors:  Nicholas N Tadros; Edmund S Sabanegh
Journal:  Indian J Urol       Date:  2017 Jul-Sep

Review 6.  Frontiers in hormone therapy for male infertility.

Authors:  Iyad Khourdaji; Haerin Lee; Ryan P Smith
Journal:  Transl Androl Urol       Date:  2018-07

7.  Clomiphene citrate ameliorated lead acetate-induced reproductive toxicity in male Wistar rats.

Authors:  Oyeyemi A Wahab; Anyanwu C Princely; Akinola A Oluwadamilare; Daramola O Ore-Oluwapo; Alli O Blessing; Ehiaghe F Alfred
Journal:  JBRA Assist Reprod       Date:  2019-10-14

8.  Baseline Gonadotropin Levels and Testosterone Response in Hypogonadal Men Treated With Clomiphene Citrate.

Authors:  Sorena Keihani; Lindsey N Wright; Nathan J Alder; Jinfeng Jiang; Philip J Cheng; Gregory J Stoddard; Alexander W Pastuszak; Christopher M Deibert; James M Hotaling
Journal:  Urology       Date:  2020-04-28       Impact factor: 2.649

Review 9.  Current medical management of endocrine-related male infertility.

Authors:  Joshua D Ring; Aye A Lwin; Tobias S Köhler
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

Review 10.  Systematic review of hormone replacement therapy in the infertile man.

Authors:  Amr El Meliegy; Ahmad Motawi; Mohamed Ahmed Abd El Salam
Journal:  Arab J Urol       Date:  2017-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.